OLMA – olema pharmaceuticals, inc. (US:NASDAQ)

News

Olema Oncology to Present at the TD Cowen 46th Annual Health Care Conference
Stifel Initiates Coverage on Olema Pharmaceuticals (OLMA) With Buy Rating [Yahoo! Finance]
Olema Pharmaceuticals CEO Teases Fall OPERA-01 Readout, Q2 KAT6 Data and CFO/COO Exit [Yahoo! Finance]
Olema Pharmaceuticals (NASDAQ:OLMA) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $48.00 price target on the stock.
Olema Oncology to Participate in Upcoming Investor Conferences
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com